EULAR 2025: MONITOR-PsA Study Confirms Feasibility of Treat-to-Target in Routine Practice
A new analysis from the MONITOR-PsA study, presented at EULAR 2025, demonstrates that a pragmatic treat-to-target (T2T) approach in psoriatic arthritis leads to promising clinical outcomes over 48 weeks.